Identification of KvLQT1 K+ channels as new regulators of non-small cell lung cancer cell proliferation and migration

International Journal of Oncology

Volumn 44, Issue 3, 2014, Pages 838-848

  Girault, Alban ^a,b   Privé, Anik ^a   Thu Ngan Trinh, Nguyen ^a,b   Bardou, Olivier ^a,b   Ferraro, Pasquale ^a,b   Joubert, Philippe ^c   Bertrand, Richard ^a,b   Brochiero, Emmanuelle ^a,b  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c LAVAL UNIVERSITY   (Canada)

Author keywords

Cell growth; K+ channels; KvLQT1; Lung cancer; Motility

Indexed keywords

CLOFILIUM; KVLQT1 POTASSIUM CHANNEL; POTASSIUM CHANNEL; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER TISSUE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER CELL PROLIFERATION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND HEALING;

ADENOCARCINOMA; CARCINOGENESIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KCNQ POTASSIUM CHANNELS; LUNG NEOPLASMS; QUATERNARY AMMONIUM COMPOUNDS; RNA, SMALL INTERFERING; WOUND HEALING;

EID: 84896710314     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.2228     Document Type: Article

References (54)

1. Berthiaume Y, Lesur O and Dagenais A: Treatment of adult respiratory distress syndrome: plea for rescue therapy of the alveolar epithelium. Thorax 54: 150-160, 1999.
2. Sacco O, Silvestri M, Sabatini F, Sale R, Defilippi AC and Rossi GA: Epithelial cells and fibroblasts: structural repair and remodelling in the airways. Paediatr Respir Rev 5 (Suppl A): S35-S40, 2004.
3. Zahm JM, Kaplan H, Herard AL, Doriot F, Pierrot D, Somelette P and Puchelle E: Cell migration and proliferation during the in vitro wound repair of the respiratory epithelium. Cell Motil Cytoskeleton 37: 33-43, 1997.
4. Crosby LM and Waters CM: Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol 298: L715-L731, 2010.
5. Hanahan D and Weinberg RA: Hallmarks of cancer: the next generation. Cell 144: 646-674, 2011.
6. Mareel M and Leroy A: Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83: 337-376, 2003.
7. Prevarskaya N, Skryma R and Shuba Y: Ion channels and the hallmarks of cancer. Trends Mol Med 16: 107-121, 2010.
8. O'Grady SM and Lee SY: Molecular diversity and function of voltage-gated (Kv) potassium channels in epithelial cells. Int J Biochem Cell Biol 37: 1578-1594, 2005.
9. Wonderlin WF and Strobl JS: Potassium channels, proliferation and G1 progression. J Membr Biol 154: 91-107, 1996.
10. Villalonga N, Ferreres JC, Argiles JM, Condom E and Felipe A: Potassium channels are a new target field in anticancer drug design. Recent Pat Anticancer Drug Discov 2: 212-223, 2007.
11. Schwab A, Hanley P, Fabian A and Stock C: Potassium channels keep mobile cells on the go. Physiology 23: 212-220, 2008.
12. Arcangeli A, Crociani O, Lastraioli E, Masi A, Pillozzi S and Becchetti A: Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr Med Chem 16: 66-93, 2009.
13. Girault A, Haelters JP, Potier-Cartereau M, Chantome A, Jaffres PA, Bougnoux P, Joulin V and Vandier C: Targeting SKCa channels in cancer: potential new therapeutic approaches. Curr Med Chem 19: 697-713, 2012.
14. Afrasiabi E, Hietamaki M, Viitanen T, Sukumaran P, Bergelin N and Tornquist K: Expression and significance of HERG (KCNH2) potassium channels in the regulation of MDA-MB-435S melanoma cell proliferation and migration. Cell Signal 22: 57-64, 2010.
15. Huang L, Li B, Li W, Guo H and Zou F: ATP-sensitive potassium channels control glioma cells proliferation by regulating ERK activity. Carcinogenesis 30: 737-744, 2009.
16. + channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry. Oncogene 28: 1792-1806, 2009.
17. Alvarez-Baron CP, Jonsson P, Thomas C, Dryer SE and Williams C: The two-pore domain potassium channel KCNK5: induction by estrogen receptor alpha and role in proliferation of breast cancer cells. Mol Endocrinol 25: 1326-1336, 2011.
18. + channels in EGF-stimulated alveolar epithelial cell repair processes. Am J Physiol Lung Cell Mol Physiol 293: L870-L882, 2007.
19. + channel activity control normal and cystic fibrosis bronchial epithelia repair. Am J Physiol Lung Cell Mol Physiol 295: L866-L880, 2008.
20. Jang SH, Choi SY, Ryu PD and Lee SY: Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo. Eur J Pharmacol 651: 26-32, 2011.
21. Plummer HK, III, Dhar MS, Cekanova M and Schuller HM: Expression of G-protein inwardly rectifying potassium channels (GIRKs) in lung cancer cell lines. BMC Cancer 5: 104, 2005.
22. + conductance and cell proliferation in small-cell lung cancer. Anticancer Res 13: 1231-1234, 1993.
23. Wang ZH, Shen B, Yao HL, Jia YC, Ren J, Feng YJ and Wang YZ: Blockage of intermediate-conductance-Ca(2+) -activated K(+) channels inhibits progression of human endometrial cancer. Oncogene 26: 5107-5114, 2007.
24. Gomez-Varela D, Zwick-Wallasch E, Knotgen H, Sanchez A, Hettmann T, Ossipov D, Weseloh R, Contreras-Jurado C, Rothe M, Stuhmer W and Pardo LA: Monoclonal antibody blockade of the human Eag1 potassium channel function exerts antitumor activity. Cancer Res 67: 7343-7349, 2007.
25. Felipe A, Vicente R, Villalonga N, Roura-Ferrer M, Martinez-Marmol R, Sole L, Ferreres JC and Condom E: Potassium channels: new targets in cancer therapy. Cancer Detect Prev 30: 375-385, 2006.
26. Woodfork KA, Wonderlin WF, Peterson VA and Strobl JS: Inhibition of ATP-sensitive potassium channels causes reversible cell-cycle arrest of human breast cancer cells in tissue culture. J Cell Physiol 162: 163-171, 1995.
27. + channels are associated with cell proliferation and cell cycle of ovarian cancer cell. Gynecol Oncol 104: 455-460, 2007.
28. Restrepo-Angulo I, Sanchez-Torres C and Camacho J: Human EAG1 potassium channels in the epithelial-to-mesenchymal transition in lung cancer cells. Anticancer Res 31: 1265-1270, 2011.
29. Hammadi M, Chopin V, Matifat F, Dhennin-Duthille I, Chasseraud M, Sevestre H and Ouadid-Ahidouch H: Human ether a-gogo K(+) channel 1 (hEag1) regulates MDA-MB-231 breast cancer cell migration through Orai1-dependent calcium entry. J Cell Physiol 227: 3837-3846, 2012.
30. Yasukagawa T, Niwa Y, Simizu S and Umezawa K: Suppression of cellular invasion by glybenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells. FEBS Lett 586: 1504-1509, 2012.
31. Potier M, Joulin V, Roger S, Besson P, Jourdan ML, Leguennec JY, Bougnoux P and Vandier C: Identification of SK3 channel as a new mediator of breast cancer cell migration. Mol Cancer Ther 5: 2946-2953, 2006.
32. Mu D, Chen L, Zhang X, See LH, Koch CM, Yen C, Tong JJ, Spiegel L, Nguyen KC, Servoss A, Peng Y, Pei L, Marks JR, Lowe S, Hoey T, Jan LY, McCombie WR, Wigler MH and Powers S: Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell 3: 297-302, 2003.
33. Ohya S, Kimura K, Niwa S, Ohno A, Kojima Y, Sasaki S, Kohri K and Imaizumi Y: Malignancy grade-dependent expression of k(+)-channel subtypes in human prostate cancer. J Pharmacol Sci 109: 148-151, 2009.
34. Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, Mansukhani M, Robinson RB, Cordon-Cardo C and Feinmark SJ: TREK-1 is a novel molecular target in prostate cancer. Cancer Res 68: 1197-1203, 2008.
35. Tsevi I, Vicente R, Grande M, Lopez-Iglesias C, Figueras A, Capella G, Condom E and Felipe A: KCNQ1/KCNE1 channels during germ-cell differentiation in the rat: expression associated with testis pathologies. J Cell Physiol 202: 400-410, 2005.
36. Than BL, Goos JA, Sarver AL, O'Sullivan MG, Rod A, Starr TK, Fijneman RJ, Meijer GA, Zhao L, Zhang Y, Largaespada DA, Scott PM and Cormier RT: The role of KCNQ1 in mouse and human gastrointestinal cancers. Oncogene: Aug 26, 2013 (Epub ahead of print). doi: 10.1038/onc.2013.350.
37. Travis WD, Brambilla E, Noguchi M, Nicholson AG, Geisinger KR, Yatabe Y, Beer DG, Powell CA, Riely GJ, Van Schil PE, Garg K, Austin JH, Asamura H, Rusch VW, Hirsch FR, Scagliotti G, Mitsudomi T, Huber RM, Ishikawa Y, Jett J, Sanchez-Cespedes M, Sculier JP, Takahashi T, Tsuboi M, Vansteenkiste J, Wistuba I, Yang PC, Aberle D, Brambilla C, Flieder D, Franklin W, Gazdar A, Gould M, Hasleton P, Henderson D, Johnson B, Johnson D, Kerr K, Kuriyama K, Lee JS, Miller VA, Petersen I, Roggli V, Rosell R, Saijo N, Thunnissen E, Tsao M and Yankelewitz D: International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 6: 244-285, 2011.
38. Maille E, Trinh NT, Prive A, Bilodeau C, Bissonnette E, Grandvaux N and Brochiero E: Regulation of normal and cystic fibrosis airway epithelial repair processes by TNF-alpha after injury. Am J Physiol Lung Cell Mol Physiol 301: L945-L955, 2011.
39. Trinh NT, Bardou O, Prive A, Maille E, Adam D, Lingée S, Ferraro P, Desrosiers M, Coraux C and Brochiero E: Improvement of defective cystic fibrosis airway epithelial wound repair after CFTR rescue. Eur Respir J 40: 1390-1400, 2012.
40. Bardou O, Prive A, Migneault F, Roy-Camille K, Dagenais A, Berthiaume Y and Brochiero E: K(+) channels regulate ENaC expression via changes in promoter activity and control fluid clearance in alveolar epithelial cells. Biochim Biophys Acta 1818: 1682-1690, 2012.
41. Wang Q, Curran ME, Splawski I, Burn TC, Millholland JM, VanRaay TJ, Shen J, Timothy KW, Vincent GM, de Jager T, Schwartz PJ, Toubin JA, Moss AJ, Atkinson DL, Landes GM, Connors TD and Keating MT: Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 12: 17-23, 1996.
42. + channels underlying anion secretion in the human airway cell line Calu-3. J Physiol 538: 747-757, 2002.
43. Devor DC, Bridges RJ and Pilewski JM: Pharmacological modulation of ion transport across wild-type and DeltaF508 CFTR-expressing human bronchial epithelia. Am J Physiol Cell Physiol 279: C461-C479, 2000.
44. + conductance in maintaining Cl- secretion in murine nasal and colonic epithelia. J Physiol 510: 237-247, 1998.
45. Ouadid-Ahidouch H and Ahidouch A: K(+) channels and cell cycle progression in tumor cells. Front Physiol 4: 220, 2013.
46. +-absorbing H441 human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 292: L1304-L1312, 2007.
47. Asher V, Warren A, Shaw R, Sowter H, Bali A and Khan R: The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line. Cancer Cell Int 11: 6, 2011.
48. Perry M, Stansfeld PJ, Leaney J, Wood C, de Groot MJ, Leishman D, Sutcliffe MJ and Mitcheson JS: Drug binding interactions in the inner cavity of HERG channels: molecular insights from structure-activity relationships of clofilium and ibutilide analogs. Mol Pharmacol 69: 509-519, 2006.
49. + channel T ASK-2 (KCNK5) by changes in cell volume. J Biol Chem 276: 43166-43174, 2001.
50. Pardo LA: Voltage-gated potassium channels in cell proliferation. Physiology 19: 285-292, 2004.
51. Klimatcheva E and Wonderlin WF: An ATP-sensitive K(+) current that regulates progression through early G1 phase of the cell cycle in MCF-7 human breast cancer cells. J Membr Biol 171: 35-46, 1999.
52. Arcangeli A and Becchetti A: Complex functional interaction between integrin receptors and ion channels. Trends Cell Biol 16: 631-639, 2006.
53. + channel function. Proc Natl Acad Sci USA 100: 7803-7807, 2003.
54. + channel protein expression decreases cell proliferation of human small cell lung cancer cells. Pflugers Arch 463: 365-376, 2012.